Faculty profile

Peter Siegel

ResearcherExperimental MedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Peter Siegel

Researcher

Experimental Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2021.
Principal investigator on 10 research grants (9 CIHR, 1 SSHRC), most recently in 2025.
Supervisor on 9 trainee awards (9 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

407

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Liver Metastasis Patient-Derived Xenografts Metastasis Cancer Metabolism Colorectal Cancer Immunotherapy Syngeneic Mouse Models

Latest papers

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.
Communications biology · 2021
GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
BMC cancer · 2018
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
Oncogene · 2018

All 13 publications

Latest funding

Unraveling Neutrophil Polarization: Deciphering How Inflammatory Signals and Metabolic Rewiring Shape Neutrophil Functions in Breast Cancer
CIHR · 2025 · Co-investigator
$1,139,850
Defining Metabolic Vulnerabilities in Replacement and Desmoplastic Colorectal Cancer Liver Metastases
CIHR · 2025 · Nominated PI
$1,071,000
Single Cell Metabolomics: Uncovering Metabolic Heterogeneity and Revealing Novel Aspects of Tissue Architecture
SSHRC · 2023 · Principal investigator
$249,276

All 28 grants and awards

13 publications.

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.

Rada M, Kapelanski-Lamoureux A, Petrillo S, Tabariès S, Siegel P, Reynolds AR, Lazaris A, Metrakos P

Communications biology2021

DOI: 10.1038/s42003-021-02481-8 PMID: 34376784

GPNMB methylation: a new marker of potentially carcinogenic colon lesions.

Ashktorab H, Rahi H, Nouraie M, Shokrani B, Lee E, Haydari T, Laiyemo AO, Siegel P, Brim H

BMC cancer2018

DOI: 10.1186/s12885-018-4903-7 PMID: 30400781

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Toosi BM, El Zawily A, Truitt L, Shannon M, Allonby O, Babu M, DeCoteau J, Mousseau D, Ali M, Freywald T, Gall A, Vizeacoumar FS, Kirzinger MW, Geyer CR, Anderson DH, Kim T, Welm AL, Siegel P, Vizeacoumar FJ, Kusalik A, Freywald A

Oncogene2018

DOI: 10.1038/s41388-018-0228-x PMID: 29700392

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.

Hulea L, Gravel SP, Morita M, Cargnello M, Uchenunu O, Im YK, Lehuédé C, Ma EH, Leibovitch M, McLaughlan S, Blouin MJ, Parisotto M, Papavasiliou V, Lavoie C, Larsson O, Ohh M, Ferreira T, Greenwood C, Bridon G, Avizonis D, Ferbeyre G, Siegel P, Jones RG, Muller W, Ursini-Siegel J, St-Pierre J, Pollak M, Topisirovic I

Cell metabolism2018

DOI: 10.1016/j.cmet.2018.09.001 PMID: 30244971

Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration.

Nooh A, Zhang YL, Sato D, Rosenzweig DH, Tabariès S, Siegel P, Barralet JE, Weber MH

Journal of bone oncology2017

DOI: 10.1016/j.jbo.2017.01.001 PMID: 28138422

Future directions for bone metastasis research – highlights from the 2015 bone and the Oncologist new updates conference (BONUS)

Fernandes R, Siegel P, Komarova S, Hilton J, Addison C, Ibrahim MFK, Werier J, Dennis K, Singh G, Amir E

Journal of Bone Oncology201610 citations

DOI: 10.1016/j.jbo.2016.02.004

Featuring the guest editors: Special issue tumor microenvironment.

Singh SR, Rameshwar P, Siegel P

Cancer letters2016Senior author

DOI: 10.1016/j.canlet.2015.05.021 PMID: 26028171

Targeting tumor microenvironment in cancer therapy.

Singh SR, Rameshwar P, Siegel P

Cancer letters2016Senior author

DOI: 10.1016/j.canlet.2016.04.009 PMID: 27060765

Decreased PCSK9 expression in human hepatocellular carcinoma.

Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J, Amre R, Tabaries S, Hassanain M, Seidah NG, Maluccio M, Siegel P, Metrakos P

BMC gastroenterology2015

DOI: 10.1186/s12876-015-0371-6 PMID: 26674961

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

Liu X-Y, Gerges N, Korshunov A, Sabha N, Khuong-Quang D-A, Fontebasso AM, Fleming A, Hadjadj D, Schwartzentruber J, Majewski J

Acta Neuropathologica2012397 citations

DOI: 10.1007/s00401-012-1031-3

Something wrong or missing on this profile? Suggest a correction

Peter Siegel

Research

Latest papers

Latest funding

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.

GPNMB methylation: a new marker of potentially carcinogenic colon lesions.

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Translational and HIF-1&#x3b1;-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.

Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration.

Future directions for bone metastasis research – highlights from the 2015 bone and the Oncologist new updates conference (BONUS)

Featuring the guest editors: Special issue tumor microenvironment.

Targeting tumor microenvironment in cancer therapy.

Decreased PCSK9 expression in human hepatocellular carcinoma.

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

Single Cell Metabolomics: Uncovering Metabolic Heterogeneity and Revealing Novel Aspects of Tissue Architecture

Frequent collaborators

Jacek Majewski

Peter Metrakos

Nada Jabado

Julie St-Pierre

Anthony Kusalik

Michael Pollak

Julie St-Pierre

Darrell Mousseau

Ivan Topisirovic

Laura Hulea

Joel Werier

Urban Emmenegger

Christina Addison

Simon-Pierre Gravel

Gelareh Zadeh

Eitan Amir

Morag Park

John Hilton

Ivan Topisirovic

Gurmit Singh

Mohan Babu

William Muller

Michael Ohh

Celia Greenwood

Svetlana Komarova

Andrew Freywald

Adam Fleming

Mark Clemons

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.